- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
From Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
October 17, 2023
From Motley Fool
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
From Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
From Benzinga
Moderna confirms COVID sales guidance as shares sink on Pfizer news
October 16, 2023
From MarketWatch
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
From Benzinga
US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year
October 16, 2023
From Benzinga
From Benzinga
Is Novavax Stock a Buy Now?
October 16, 2023
From Motley Fool
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
October 16, 2023
From MarketWatch
Pfizer’s stock sinks after company cuts outlook on lower demand for COVID treatments
October 13, 2023
From MarketWatch
Novavax (NVAX) Stock Slides Despite Vaccine Availability
October 13, 2023
From InvestorPlace
The Fall Vaccination Season Is Here. Is Novavax a Buy?
October 12, 2023
Tickers
NVAX
From Motley Fool
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
From Benzinga
From Benzinga
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
From Motley Fool
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
From Benzinga
3 Pharma Stocks to Dump Before the Damage Is Done
October 08, 2023
From InvestorPlace
This Could be Novavax's Big Opportunity
October 07, 2023
From Motley Fool
From Motley Fool
Why Novavax Stock Fell Today
October 04, 2023
From Benzinga
Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum
October 04, 2023
Tickers
NVAX
From Benzinga
Why Is Tilray (TLRY) Stock Down 4% Today?
October 04, 2023
From InvestorPlace
From MarketWatch
These Apple Insiders Are Selling Shares of AAPL Stock
October 04, 2023
From InvestorPlace
Short Sellers Are Betting Against Novavax (NVAX) Stock
October 04, 2023
From InvestorPlace
What's Going On With Moderna Stock Wednesday?
October 04, 2023
From Benzinga
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
October 03, 2023
From Benzinga
Novavax updated COVID vaccine gets FDA approval
October 03, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.